Significant increase in the frequency of IFN-γ+ CD8+ (~20%) and CD4+ (~10%) T cells was found in tumors from the hetIL-15-treated group, suggesting that hetIL-15 increases the production of IFN-γ within the tumor. This evidence concerns the gene CD8A and neoplasm.